SCHEMBL2492363

SCHEMBL2492363

NCCOC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 1.00
TAAR1 Q96RJ0 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HRH4 Q9H3N8 1/20 0.44
KDM4E B2RXH2 2/20 0.42
ALOX15 P16050 2/20 0.42
TSHR P16473 2/20 0.42
MEN1 O00255 1/20 0.42
TRPM2 O94759 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
THRB P10828 1/20 0.42
HPGD P15428 1/20 0.42
ALOX12 P18054 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
DUT P33316 1/20 0.41
LTA4H P09960 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12199498 0.89 KIF11 (0.79) KIF11SMN1; SMN2TK2TK1
SCHEMBL13671082 0.88 KIF11 (0.78) KIF11TAAR1SMN1; SMN2HRH4KDM4E
SCHEMBL4454297 0.88 KIF11 (0.78) KIF11TAAR1SMN1; SMN2HRH4KDM4E
SCHEMBL11913616 0.88 KIF11 (0.78) KIF11TAAR1SMN1; SMN2HRH4KDM4E
SCHEMBL28661706 0.88 KIF11 (0.78) KIF11TAAR1SMN1; SMN2HRH4KDM4E
SCHEMBL2494600 0.87 KIF11 (0.77) KIF11SMN1; SMN2HRH4DUTTK2
SCHEMBL2490823 0.86 KIF11 (0.73) KIF11SMN1; SMN2SLC6A1
SCHEMBL3617308 0.86 KIF11 (0.73) KIF11SMN1; SMN2SLC6A1
SCHEMBL11275984 0.85 KIF11 (0.74) KIF11TAAR1HRH4ALOX15TSHR
SCHEMBL8703547 0.84 KIF11 (0.71) KIF11HRH4TK2TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US claimed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP claimed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US claimed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP claimed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US claimed
EP-4234042-B1 MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR POLA CHEM IND INC (JP) 2025-08-13 EP disclosed
US-12358867-B1 Peptoid-based inhibitors of the protein arginine methyltransferase (PRMT) family UNIVERSITY OF NORTH FLORIDA BOARD OF TRUSTEES (US) 2025-07-15 US disclosed
US-11993556-B1 Peptoid-based inhibitors of the protein arginine methyltransferase (PRMT) family UNIVERSITY OF NORTH FLORIDA BOARD OF TRUSTEES (US) 2024-05-28 US disclosed
EP-4234042-A1 MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR Pola Chemical Industries, Inc. (JP) 2023-08-30 EP disclosed
EP-3708148-B1 MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR POLA CHEM IND INC (JP) 2023-07-19 EP disclosed
CN-112402279-A Whitening cosmetic and use of composition containing D-panthenol in preparation of whitening cosmetic 宝丽化成工业有限公司 2021-02-26 CN disclosed
CN-112402285-A Whitening cosmetic and use of composition containing D-panthenol in preparation of whitening cosmetic 宝丽化成工业有限公司 2021-02-26 CN disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
US-4438260-A Sisomicin compounds BAYER AKTIENGESELLSCHAFT (DE) 1984-03-20 US disclosed
EP-0056575-A1 Sisomicin derivatives, process for their preparation and their use as pharmaceutical compositions BAYER AG (DE) 1982-07-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12358867-B1 Peptoid-based inhibitors of the protein arginine methyltransferase (PRMT) family PRMT1, PRMT3, PRMT5 KIF11 3606/4885TAAR1 4223/4885SMN1; SMN2 3387/4885
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH KIF11 4556/4885TAAR1 225/4885SMN1; SMN2 3632/4885
US-11993556-B1 Peptoid-based inhibitors of the protein arginine methyltransferase (PRMT) family PRMT1, PRMT3, PRMT5 KIF11 3606/4885TAAR1 4223/4885SMN1; SMN2 3387/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 KIF11 4605/4885TAAR1 194/4885SMN1; SMN2 3663/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R KIF11 4611/4885TAAR1 225/4885SMN1; SMN2 3592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.